{{Rsnum
|rsid=3846421
|Gene=SORCS2
|Chromosome=4
|position=7283629
|Orientation=plus
|GMAF=0.3127
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SORCS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.4 | 49.1 | 12.5
| HCB | 48.2 | 42.3 | 9.5
| JPT | 42.5 | 46.0 | 11.5
| YRI | 33.3 | 55.8 | 10.9
| ASW | 49.1 | 45.6 | 5.3
| CHB | 48.2 | 42.3 | 9.5
| CHD | 49.5 | 39.4 | 11.0
| GIH | 23.8 | 56.4 | 19.8
| LWK | 50.0 | 41.8 | 8.2
| MEX | 69.0 | 29.3 | 1.7
| MKK | 56.4 | 36.5 | 7.1
| TSI | 44.1 | 44.1 | 11.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3846421
|Name_s=
|Gene_s=SORCS2
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363852
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3846421
|overall_frequency_n=89
|overall_frequency_d=128
|overall_frequency=0.695312
|n_genomes=50
|n_genomes_annotated=0
|n_haplomes=79
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}